A citation-based method for searching scientific literature

Hsiu-Li Lin, Hsiu-Chen Lin, Yuan-Fu Tseng, Jane Chen-Jui Chao, Chien-Yeh Hsu. Ann Med 2018
Times Cited: 8







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glitazone use associated with reduced risk of Parkinson's disease.
Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
67
87

Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study.
Ruth Brauer, Krishnan Bhaskaran, Nishi Chaturvedi, David T Dexter, Liam Smeeth, Ian Douglas. PLoS Med 2015
83
87

Thiazolidinediones and Parkinson Disease: A Cohort Study.
John G Connolly, Katsiaryna Bykov, Joshua J Gagne. Am J Epidemiol 2015
26
75

Pioglitazone use and Parkinson's disease: a retrospective cohort study in Taiwan.
Hsiu-Feng Wu, Li-Ting Kao, Jui-Hu Shih, Hui-Han Kao, Yu-Ching Chou, I-Hsun Li, Senyeong Kao. BMJ Open 2018
17
75


The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
765
50


Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
122
37

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease.
Yanqin Wang, Weilin Zhao, Ge Li, Jinhu Chen, Xin Guan, Xi Chen, Zhenlong Guan. PPAR Res 2017
31
37

Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.
Salman Hussain, Ambrish Singh, Harveen Baxi, Bruce Taylor, John Burgess, Benny Antony. Neurol Sci 2020
12
37

Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Ruth Brauer, Li Wei, Tiantian Ma, Dilan Athauda, Christine Girges, Nirosen Vijiaratnam, Grace Auld, Cate Whittlesea, Ian Wong, Tom Foltynie. Brain 2020
49
37

Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study.
Sang Youl Rhee, Kyung-Do Han, Hyemi Kwon, Se-Eun Park, Yong-Gyu Park, Yang-Hyun Kim, Soon-Jip Yoo, Eun-Jung Rhee, Won-Young Lee. Diabetes Care 2020
28
37

Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus.
Y-Hu Chang, S-J Yen, Y-Ha Chang, W-J Wu, K-D Lin. Eur J Neurol 2021
8
37


Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
194
25

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Lauren Hirsch, Nathalie Jette, Alexandra Frolkis, Thomas Steeves, Tamara Pringsheim. Neuroepidemiology 2016
280
25

The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.
Christine R Swanson, Valerie Joers, Viktoriya Bondarenko, Kevin Brunner, Heather A Simmons, Toni E Ziegler, Joseph W Kemnitz, Jeffrey A Johnson, Marina E Emborg. J Neuroinflammation 2011
139
25

High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson's Disease.
Elliot Hogg, Kishore Athreya, Christina Basile, Echo E Tan, Jan Kaminski, Michele Tagliati. J Parkinsons Dis 2018
32
25


Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
139
25

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
114
25

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.
I Moroo, T Yamada, H Makino, I Tooyama, P L McGeer, E G McGeer, K Hirayama. Acta Neuropathol 1994
120
25

Does glitazone treatment have a role on the prevention of Parkinson's disease in adult diabetic population? A systematic review.
Jesús D Meléndez-Flores, Juan Manuel Millán-Alanís, Adrián González-Martínez, Neri Alejandro Álvarez-Villalobos, Ingrid Estrada-Bellmann. Metab Brain Dis 2020
4
50

Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
88
25

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
81
25

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
361
25

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
151
25

Insulin resistance impairs nigrostriatal dopamine function.
J K Morris, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford. Exp Neurol 2011
95
25

Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain.
A Morano, F J Jiménez-Jiménez, J A Molina, M A Antolín. Acta Neurol Scand 1994
127
25

Diabetes preceding Parkinson's disease onset. A case-control study.
Marco D'Amelio, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri. Parkinsonism Relat Disord 2009
50
25

Diabetes in patients with idiopathic Parkinson's disease.
Claudia Becker, Gunnar P Brobert, Saga Johansson, Susan S Jick, Christoph R Meier. Diabetes Care 2008
51
25

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
108
25

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.
Qian Shi, Shuqian Liu, Vivian A Fonseca, Tina K Thethi, Lizheng Shi. BMJ Open 2019
50
25

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
65
25

Association between Parkinson's disease and diabetes: Data from NEDICES study.
E De Pablo-Fernandez, F Sierra-Hidalgo, J Benito-León, F Bermejo-Pareja. Acta Neurol Scand 2017
38
25

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
292
25

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
169
25

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
25

Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
23
25

Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies.
Mei Xue, Wei Xu, Ya-Nan Ou, Xi-Peng Cao, Meng-Shan Tan, Lan Tan, Jin-Tai Yu. Ageing Res Rev 2019
131
25

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
46
25

Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes.
Katriina Sunnarborg, Miia Tiihonen, Marjo Huovinen, Marjaana Koponen, Sirpa Hartikainen, Anna-Maija Tolppanen. Pharmacoepidemiol Drug Saf 2022
3
66

Gender differences in Parkinson's disease.
Charlotte A Haaxma, Bastiaan R Bloem, George F Borm, Wim J G Oyen, Klaus L Leenders, Silvia Eshuis, Jan Booij, Dean E Dluzen, Martin W I M Horstink. J Neurol Neurosurg Psychiatry 2007
417
12

Pioglitazone reduces mortality, prevents depressive-like behavior, and impacts hippocampal neurogenesis in the 6-OHDA model of Parkinson's disease in rats.
Jéssica Mendes Bonato, Taysa Bervian Bassani, Humberto Milani, Maria Aparecida Barbato Frazão Vital, Rúbia Maria Weffort de Oliveira. Exp Neurol 2018
31
12

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
12

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
12

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
12

The prevalence of Parkinson's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Nathalie Jette, Alexandra Frolkis, Thomas D L Steeves. Mov Disord 2014
12

Pioglitazone: side effect and safety profile.
Priya Shah, Sunder Mudaliar. Expert Opin Drug Saf 2010
137
12

Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
Milena Pinto, Nadee Nissanka, Susana Peralta, Roberta Brambilla, Francisca Diaz, Carlos T Moraes. Mol Neurodegener 2016
41
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.